  See all
 |
Articles: Myeloproliferative Dz |
Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study
Bone Marrow Transplantation, 12/03/08
Whole Body Radiography for Bone Survey Screening of Cancer and Myeloma Patients
Cancer Investigation, 12/03/08 Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing
Cancer Genetics and Cytogenetics, 12/03/08 A new prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
Blood, 12/02/08
Evidence Based Medicine
Wilms Tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma
International Journal of Hematology, 12/02/08 Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
International Journal of Hematology, 12/02/08 Transcription factors Xbp-1, Blimp-1, and BSAP are involved in the regulation of plasmacytic differentiation induced by 2-methoxyestradiol in myeloma cell lines
International Journal of Hematology, 12/02/08 An analysis of complex chromosomal aberrations in seven cases of myelodysplastic syndromes by M-FISH and whole chromosome painting
International Journal of Hematology, 12/02/08 Comorbidity predicts survival in myelodysplastic syndromes or secondary acute myeloid leukaemia after allogeneic stem cell transplantation
European Journal of Clinical Investigation, 11/26/08 Multiple myeloma in chronic kidney disease
Nephron: Clinical Practice, 11/26/08 International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
Leukemia, 11/26/08 Treatment of newly diagnosed myeloma
Leukemia, 11/25/08
Revew Article
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program
British Journal of Haematology, 11/24/08 Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of Clinical Oncology, 11/20/08
Evidence Based Medicine
Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms
Leukemia, 11/20/08 Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
Therapeutics and Clinical Risk Management, 11/19/08 Thalidomide-dexamethasone compared to melphalan-prednisolone in elderly patients with multiple myeloma
Blood, 11/18/08
Evidence Based Medicine
Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33+ primary resistant or relapsed acute myeloid leukemia
Journal of Clinical Oncology, 11/17/08 Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomi
Leukemia Research, 11/17/08 Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): Clinicopathologic comparison of del(5q)-positive and -negative cases
Leukemia Research, 11/17/08
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
190 Available Pages
|
|
